[English] 日本語
Yorodumi- EMDB-70919: Composite map of GluA1/A2 in the activated state, in complex with... -
+
Open data
-
Basic information
| Entry | ![]() | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD) | ||||||||||||||||||||||||||||||
Map data | A1A2 rr2b glu composite map (LBD-TMD) | ||||||||||||||||||||||||||||||
Sample |
| ||||||||||||||||||||||||||||||
Keywords | GluA1A2 heterotetramer active iGluR / MEMBRANE PROTEIN | ||||||||||||||||||||||||||||||
| Function / homology | Function and homology informationCargo concentration in the ER / axonal spine / cellular response to ammonium ion / COPII-mediated vesicle transport / positive regulation of locomotion involved in locomotory behavior / positive regulation of membrane potential / response to sucrose / regulation of monoatomic ion transmembrane transport / cellular response to L-glutamate / myosin V binding ...Cargo concentration in the ER / axonal spine / cellular response to ammonium ion / COPII-mediated vesicle transport / positive regulation of locomotion involved in locomotory behavior / positive regulation of membrane potential / response to sucrose / regulation of monoatomic ion transmembrane transport / cellular response to L-glutamate / myosin V binding / neuron spine / Trafficking of AMPA receptors / proximal dendrite / response to arsenic-containing substance / cellular response to dsRNA / long-term synaptic depression / ligand-gated calcium channel activity / dendritic spine membrane / beta-2 adrenergic receptor binding / Synaptic adhesion-like molecules / cellular response to peptide hormone stimulus / spinal cord development / regulation of synaptic plasticity by chemical substance / spine synapse / dendritic spine neck / dendritic spine cytoplasm / cellular response to amine stimulus / response to phorbol 13-acetate 12-myristate / dendritic spine head / response to psychosocial stress / peptide hormone receptor binding / response to morphine / Activation of AMPA receptors / ligand-gated monoatomic cation channel activity / perisynaptic space / behavioral response to pain / neuronal cell body membrane / response to lithium ion / Trafficking of GluR2-containing AMPA receptors / protein kinase A binding / AMPA glutamate receptor activity / AMPA glutamate receptor clustering / regulation of receptor recycling / neuronal action potential / kainate selective glutamate receptor activity / response to electrical stimulus / adenylate cyclase binding / AMPA glutamate receptor complex / extracellularly glutamate-gated ion channel activity / ionotropic glutamate receptor complex / cellular response to glycine / immunoglobulin binding / asymmetric synapse / Unblocking of NMDA receptors, glutamate binding and activation / response to fungicide / G-protein alpha-subunit binding / glutamate receptor binding / positive regulation of synaptic transmission / long-term memory / conditioned place preference / regulation of synaptic transmission, glutamatergic / postsynaptic density, intracellular component / cytoskeletal protein binding / extracellular ligand-gated monoatomic ion channel activity / glutamate-gated receptor activity / cellular response to brain-derived neurotrophic factor stimulus / regulation of long-term synaptic depression / synapse assembly / glutamate-gated calcium ion channel activity / somatodendritic compartment / presynaptic active zone membrane / ionotropic glutamate receptor binding / excitatory synapse / ionotropic glutamate receptor signaling pathway / ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential / dendrite cytoplasm / dendrite membrane / cellular response to amino acid stimulus / response to cocaine / positive regulation of excitatory postsynaptic potential / SNARE binding / establishment of protein localization / synaptic membrane / neuromuscular junction / synaptic transmission, glutamatergic / PDZ domain binding / cerebral cortex development / response to toxic substance / dendritic shaft / transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential / protein tetramerization / long-term synaptic potentiation / receptor internalization / response to nutrient levels / regulation of synaptic plasticity / recycling endosome / cellular response to growth factor stimulus / postsynaptic density membrane / Schaffer collateral - CA1 synapse / modulation of chemical synaptic transmission Similarity search - Function | ||||||||||||||||||||||||||||||
| Biological species | ![]() | ||||||||||||||||||||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.2 Å | ||||||||||||||||||||||||||||||
Authors | Yen LY / Sobolevsky AI / Newton TP / Gangwar SP | ||||||||||||||||||||||||||||||
| Funding support | United States, 9 items
| ||||||||||||||||||||||||||||||
Citation | Journal: Nat Commun / Year: 2026Title: Auxiliary subunits reshape structural asymmetry and functional plasticity in heterotetrameric GluA1/A2 AMPA receptor core. Authors: Laura Y Yen / Thomas P Newton / Maria V Yelshanskaya / Muhammed Aktolun / Shanti Pal Gangwar / Rasmus P Clausen / Maria G Kurnikova / Alexander I Sobolevsky / ![]() Abstract: AMPA-subtype ionotropic glutamate receptors (AMPARs) mediate the fast component of excitatory neurotransmission. They govern synaptic plasticity that underlies learning and memory, while their ...AMPA-subtype ionotropic glutamate receptors (AMPARs) mediate the fast component of excitatory neurotransmission. They govern synaptic plasticity that underlies learning and memory, while their dysregulation is implicated in numerous neurological disorders. The functional diversity of AMPARs arises from variations in their subunit composition and also their association with auxiliary subunits. While multiple structures of homomeric AMPARs have been reported, structural information for the heteromeric core - particularly in the absence of auxiliary subunits, which would serve as a functional and structural baseline - has been limited. Here, we report cryo-electron microscopy structures of GluA1/A2, the most abundant AMPAR di-heteromer in the brain, in the closed, open, and desensitized states. Using molecular dynamics (MD) simulations and cross-correlating structural and functional information, we find that auxiliary subunits increase the diameter of channel pore, which corresponds to larger conductance. Likewise, we find that recovery from desensitization slows with greater disruption of two-fold rotational symmetry of the ligand-binding domain dimer in the desensitized state. Both receptor activation and desensitization vary with the type and number of associated auxiliary proteins. These structures offer a foundation for uncovering how auxiliary subunits reshape structural asymmetry and functional plasticity in heterotetrameric AMPARs. | ||||||||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_70919.map.gz | 237.6 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-70919-v30.xml emd-70919.xml | 22.7 KB 22.7 KB | Display Display | EMDB header |
| Images | emd_70919.png | 1.4 MB | ||
| Filedesc metadata | emd-70919.cif.gz | 7.7 KB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-70919 ftp://data.pdbj.org/pub/emdb/structures/EMD-70919 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9ovuMC ![]() 9ovtC ![]() 9ovvC ![]() 9ovwC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_70919.map.gz / Format: CCP4 / Size: 274.6 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | A1A2 rr2b glu composite map (LBD-TMD) | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.83 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-
Sample components
-Entire : Heteromeric GluA1A2 with positive allosteric modulator (R,R)-2b a...
| Entire | Name: Heteromeric GluA1A2 with positive allosteric modulator (R,R)-2b and agonist glutamate (Glu) |
|---|---|
| Components |
|
-Supramolecule #1: Heteromeric GluA1A2 with positive allosteric modulator (R,R)-2b a...
| Supramolecule | Name: Heteromeric GluA1A2 with positive allosteric modulator (R,R)-2b and agonist glutamate (Glu) type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 556 KDa |
-Macromolecule #1: Isoform Flip of Glutamate receptor 1
| Macromolecule | Name: Isoform Flip of Glutamate receptor 1 / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 94.483922 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MPYIFAFFCT GFLGAVVGAN FPNNIQIGGL FPNQQSQEHA AFRFALSQLT EPPKLLPQID IVNISDSFEM TYRFCSQFSK GVYAIFGFY ERRTVNMLTS FCGALHVCFI TPSFPVDTSN QFVLQLRPEL QEALISIIDH YKWQTFVYIY DADRGLSVLQ R VLDTAAEK ...String: MPYIFAFFCT GFLGAVVGAN FPNNIQIGGL FPNQQSQEHA AFRFALSQLT EPPKLLPQID IVNISDSFEM TYRFCSQFSK GVYAIFGFY ERRTVNMLTS FCGALHVCFI TPSFPVDTSN QFVLQLRPEL QEALISIIDH YKWQTFVYIY DADRGLSVLQ R VLDTAAEK NWQVTAVNIL TTTEEGYRML FQDLEKKKER LVVVDCESER LNAILGQIVK LEKNGIGYHY ILANLGFMDI DL NKFKESG ANVTGFQLVN YTDTIPARIM QQWRTSDSRD HTRVDWKRPK YTSALTYDGV KVMAEAFQSL RRQRIDISRR GNA GDCLAN PAVPWGQGID IQRALQQVRF EGLTGNVQFN EKGRRTNYTL HVIEMKHDGI RKIGYWNEDD KFVPAGGDNS SVQN RTYIV TTILEDPYVM LKKNANQFEG NDRYEGYCVE LAAEIAKHVG YSYRLEIVSD GKYGARDPDT KAWNGMVGEL VYGRA DVAV APLTITLVRE EVIDFSKPFM SLGISIMIKK PQKSKPGVFS FLDPLAYEIW MCIVFAYIGV SVVLFLVSRF SPYEWH SEE FEEGRDQTTS DQSNEFGIFN SLWFSLGAFM QQGCDISPRS LSGRIVGGVW WFFTLIIISS YTANLAAFLT VERMVSP IE SAEDLAKQTE IAYGTLEAGS TKEFFRRSKI AVFEKMWTYM KSAEPSVFVR TTEEGMIRVR KSKGKYAYLL ESTMNEYI E QRKPCDTMKV GGNLDSKGYG IATPKGSALR GPVNLAVLKL SEQGVLDKLK SKWWYDKGEC GSKDSGSKDK TSALSLSNV AGVFYILIGG LGLAMLVALI EFCYKSRSES KRMKG UniProtKB: Glutamate receptor 1 |
-Macromolecule #2: Isoform Flip of Glutamate receptor 2
| Macromolecule | Name: Isoform Flip of Glutamate receptor 2 / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 94.369961 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGKIMHISVL LSPVLWGLIF GVSSNSIQIG GLFPRGADQE YSAFRVGMVQ FSTSEFRLTP HIDNLEVANS FAVTNAFCSQ FSRGVYAIF GFYDKKSVNT ITSFCGTLHV SFITPSFPTD GTHPFVIQMR PDLKGALLSL IEYYQWDKFA YLYDSDRGLS T LQAVLDSA ...String: MGKIMHISVL LSPVLWGLIF GVSSNSIQIG GLFPRGADQE YSAFRVGMVQ FSTSEFRLTP HIDNLEVANS FAVTNAFCSQ FSRGVYAIF GFYDKKSVNT ITSFCGTLHV SFITPSFPTD GTHPFVIQMR PDLKGALLSL IEYYQWDKFA YLYDSDRGLS T LQAVLDSA AEKKWQVTAI NVGNINNDKK DETYRSLFQD LELKKERRVI LDCERDKVND IVDQVITIGK HVKGYHYIIA NL GFTDGDL LKIQFGGAEV SGFQIVDYDD SLVSKFIERW STLEEKEYPG AHTATIKYTS ALTYDAVQVM TEAFRNLRKQ RIE ISRRGN AGDCLANPAV PWGQGVEIER ALKQVQVEGL SGNIKFDQNG KRINYTINIM ELKTNGPRKI GYWSEVDKMV LTED DTSGL EQKTVVVTTI LESPYVMMKK NHEMLEGNER YEGYCVDLAA EIAKHCGFKY KLTIVGDGKY GARDADTKIW NGMVG ELVY GKADIAIAPL TITLVREEVI DFSKPFMSLG ISIMIKKPQK SKPGVFSFLD PLAYEIWMCI VFAYIGVSVV LFLVSR FSP YEWHTEEFED GRETQSSEST NEFGIFNSLW FSLGAFMRQG CDISPRSLSG RIVGGVWWFF TLIIISSYTA NLAAFLT VE RMVSPIESAE DLSKQTEIAY GTLDSGSTKE FFRRSKIAVF DKMWTYMRSA EPSVFVRTTA EGVARVRKSK GKYAYLLE S TMNEYIEQRK PCDTMKVGGN LDSKGYGIAT PKGSSLGTPV NLAVLKLSEQ GVLDKLKNKW WYDKGECGAK DSGSKEKTS ALSLSNVAGV FYILVGGLGL AMLVALIEFC YKSRAEAKRM KG UniProtKB: Glutamate receptor 2 |
-Macromolecule #5: GLUTAMIC ACID
| Macromolecule | Name: GLUTAMIC ACID / type: ligand / ID: 5 / Number of copies: 4 / Formula: GLU |
|---|---|
| Molecular weight | Theoretical: 147.129 Da |
| Chemical component information | ![]() ChemComp-GLU: |
-Macromolecule #6: SODIUM ION
| Macromolecule | Name: SODIUM ION / type: ligand / ID: 6 / Number of copies: 1 |
|---|---|
| Molecular weight | Theoretical: 22.99 Da |
-Macromolecule #7: N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide
| Macromolecule | Name: N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide type: ligand / ID: 7 / Number of copies: 2 / Formula: FWF |
|---|---|
| Molecular weight | Theoretical: 480.684 Da |
| Chemical component information | ![]() ChemComp-FWF: |
-Macromolecule #8: water
| Macromolecule | Name: water / type: ligand / ID: 8 / Number of copies: 4 / Formula: HOH |
|---|---|
| Molecular weight | Theoretical: 18.015 Da |
| Chemical component information | ![]() ChemComp-HOH: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 4.5 mg/mL | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 8 Component:
Details: 150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 0.05% digitonin, 500 uM (R,R)-2b, 1 mM glutamate | ||||||||||||||||||
| Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: GOLD / Support film - topology: HOLEY / Support film - Film thickness: 500 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 25 sec. / Pretreatment - Atmosphere: AIR / Details: 15 mA | ||||||||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 298 K / Instrument: FEI VITROBOT MARK IV | ||||||||||||||||||
| Details | The sample had compositional heterogeneity, with broken particles seen throughout. Otherwise, sample was monodisperse |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 47.03 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 100.0 µm / Illumination mode: SPOT SCAN / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.0 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Authors
United States, 9 items
Citation


























Z (Sec.)
Y (Row.)
X (Col.)




















Homo sapiens (human)


Processing
FIELD EMISSION GUN
